Zacks Investment Research on MSN
MRNA stock jumps on global submissions seeking nod for flu vaccine
Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 ...
5d
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...
Inside a single-story brick building in Sorrento Mesa is a small lab sprinkled with beakers, test tubes and incubators that ...
Flu cases are climbing across the United States as the season reaches its peak, and millions of people may get sick in the ...
The FDA plans to tighten vaccine approval standards, requiring more evidence of safety and efficacy. Georgia doctors warn the move could discourage vaccination and reduce vaccine development. The ...
In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, the first ...
The United States on Monday dropped its recommendation that all children be vaccinated against influenza and three other ...
In the study, no matter how much weight participants lost, regain was four times faster for people ending medication use than ...
In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback